Cellomatics Biosciences Ltd Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Its work serves teams developing novel therapeutics, validating biomarkers, and advancing translational research by delivering robust data from concept through to completion. Based in Carlton, in the East Midlands region of England, the firm combines scientific expertise with access to fresh donor material sourced via an in-house volunteer recruitment and recall system to deliver reliable, reproducible results. In 2025, Cellomatics launched INNOBEX, its proprietary Blood-Brain Barrier model, alongside new commercial platforms in NASH and pulmonary fibrosis.